Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population‐Based Cohort Study [PDF]
Journal of the American Heart Association, 2022 Background Commonly prescribed diabetic medications such as metformin and sulfonylurea may be associated with different arrhythmogenic risks. This study compared the risk of ventricular arrhythmia or sudden cardiac death between metformin and ...
Wong Ick, Abraham Ka-Chung Wai
exaly +4 more sources
Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment [PDF]
Diabetes & Metabolism Journal, 2016 BackgroundThere were a limited number of studies about β-cell function after insulin initiation in patients exposed to long durations of sulfonylurea treatment.
Yeoree Yang +7 more
doaj +2 more sources
Journal of Diabetes Investigation, 2022 Aims/Introduction Aging of society is accelerating in many countries. The purpose of this study was to describe the clinical features and sulfonylurea usage among diabetes outpatients aged ≥90 years (nonagenarians). Materials and Methods This study was a
Toshiko Kobori +8 more
doaj +2 more sources
Unintentional sulfonylurea toxicity due to a drug–drug interaction: a case report [PDF]
BMC Research Notes, 2018 Background Sulfonylureas are widely used for type 2 diabetes mellitus, but these medications carry a risk of hypoglycemia. Drug–drug interactions that inhibit sulfonylurea metabolism and thus increase systemic exposure can cause unintentional ...
Keith Gunaratne +2 more
doaj +2 more sources
Ecotoxicology and Environmental SafetySulfonylureas are widely used herbicides globally; however, the health risks associated with exposure to these compounds are poorly understood. This study used fuzzy clustering to categorize 44 sulfonylurea compounds into three risk priority levels (I ...
Zhi-Cong He +5 more
doaj +2 more sources
Biochimica Et Biophysica Acta - Molecular Cell Research, 1992 Frances Ashcroft +2 more
exaly +3 more sources
Risk of new-onset prostate cancer for Metformin versus Sulfonylurea use in Type 2 Diabetes Mellitus: A propensity score-matched study [PDF]
, 2022 The aim of this study was to compare the risks of new-onset prostate cancer between metformin and sulfonylurea users with type 2 diabetes mellitus (T2DM).
Liu, Xuejin +14 more
core +2 more sources
Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2018 Permanent neonatal diabetes mellitus is most commonly caused by mutations in the ATP-sensitive potassium channel (KATP) subunits. Prompt initiation of sulfonylurea treatment can improve glycemic control in children with KCNJ11 mutation.
Jong Seo Yoon +4 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Metformin and sulfonylurea are commonly prescribed oral medications for type 2 diabetes mellitus. The association of metformin and sulfonylureas on heart failure outcomes in patients with reduced estimated glomerular filtration rate remains ...
Tadarro L. Richardson +7 more
doaj +1 more source
Sulfonylurea and Cancer Risk Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
Frontiers in Endocrinology, 2022 BackgroundCurrent evidence of the association between the use of sulfonylurea and cancer risk is highly conflicting and little evidence of this association is from the mainland Chinese population.
Houyu Zhao +8 more
doaj +1 more source